Glucose Control and Cardiovascular Complications: The VA Diabetes Trial-Reference-Cited by-同舟云学术

Glucose Control and Cardiovascular Complications: The VA Diabetes Trial

Published:2001-05-01 Issue:5 Volume:24 Page:942-945
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Duckworth William C.¹²³,McCarren Madeline⁴,Abraira Carlos⁵⁶

Affiliation:

1. Endocrinology Section, Carl T. Hayden VA Medical Center, Phoenix

2. Molecular and Cellular Biology Program, Arizona State University, Tempe

3. Department of Medicine, University of Arizona, Tucson, Arizona

4. Cooperative Studies Program Coordinating Center, Department of Veterans Affairs, VA Hines Hospital, Hines, Illinois

5. Research Service and Endocrinology Section, Miami VA Medical Center

6. Division of Endocrinology, University of Miami Medical School, Miami, Florida

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/24/5/942/643831/942.pdf

Reference22 articles.

1. Geiss S, Herman WH, Smith PJ: Mortality in non-insulin-dependent diabetes. In Diabetes in America/National Diabetes Data Group. 2nd Ed. Harris M., Ed. Bethesda, Maryland, National Institutes of Health, 1995, p. 133–155 (NIH publ no. 95-1468)

2. The Diabetes Control and Complication Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986, 1993

3. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risks of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, 1998

4. Shichiri M, Ohkubo Y, Kishikawa H, Wake N: Long-term results of the Kumamoto study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23(Suppl. 2):B21–B29, 2000

5. Vijan S, Hofer T, Hayward R: Estimated benefits of glycemic control in microvascular complications in type 2 diabetes. Ann Intern Med 127:788–795, 1997

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Sitagliptin as Monotherapy and Add-On to Metformin on Weight Loss among Overweight and Obese Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis;Drug Research;2021-08-13

2. Efficacy and safety of the glucagon-like peptide-1 receptor agonist oral semaglutide in patients with type 2 diabetes mellitus: A systematic review and meta-analysis;Diabetes Research and Clinical Practice;2021-02

3. (New antidiabetics and cardiovascular safety in the light of clinical trials);Cor et Vasa;2019-12-15

4. Cardiovascular complications in diabetes mellitus: the role of hyperglycemia;Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini;2019-12-12

5. Frequency of Gestational Diabetes Mellitus Reappearance or Absence during the Second Pregnancy of Women Treated at Mayo Clinic between 2013 and 2018;Journal of Diabetes Research;2019-11-22